ZHANG Juntao 1,2 , LIU Anru 1,2 , WAN Lijun 1,2 , HAN Tao 1,2 , LIU Xuewu 1,2
  • 1. Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250022, China;
  • 2. Epilepsy Research Institute of Shandong University, Jinan 250022, China;
LIU Xuewu, Email: snlxw1966@163.com
Export PDF Favorites Scan Get Citation

Epilepsy is a common chronic neurological disorder. Drug-resistant epilepsy (DRE) is defined as failure to achieve sustained seizure freedom after adequate trials of two appropriately chosen and tolerated anti-seizure medications (ASMs) regimens (as monotherapies or in combination). In this population, surgical resection and neuromodulation can effectively reduce seizure burden; however, their effectiveness is limited by uncertainty in epileptogenic zone localization, interindividual variability in stimulation targets and parameters, and procedure-related risks. As an emerging technology, brain–computer interface (BCI) offer a closed-loop framework of real-time monitoring, state decoding, decision-making, and intervention delivery, shifting therapy from fixed-parameter open-loop approaches to biomarker-driven, dynamically personalized modulation and providing new avenues for precision, individualized treatment of DRE. This review summarizes signal acquisition and decoding strategies for epilepsy BCI, closed-loop intervention paradigms, and key challenges in clinical translation.

Citation: ZHANG Juntao, LIU Anru, WAN Lijun, HAN Tao, LIU Xuewu. Progress and translational challenges of brain-computer interfaces in the treatment of drug resistant epilepsy. Journal of Epilepsy, 2026, 12(2): 152-158. doi: 10.7507/2096-0247.202601002 Copy

Copyright ? the editorial department of Journal of Epilepsy of West China Medical Publisher. All rights reserved

  • Previous Article

    Vagus nerve stimulation in the treatment of drug-resistant epilepsy: progress and prospects
  • Next Article

    癲癇發作伴光敏感的下丘腦錯構瘤一例